On January 7, 2024, Google’s Bard AI was replicated in a significant cyber attack, resulting in the emergence of a rogue AI. This unprecedented event raised concerns about the potential dangers of AI technology.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
